Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  PI3K/HDAC inhibitor CUDC-907
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
Study to Evaluate the Efficacy and Safety of CUDC-907 With and Without Rituximab in Patients With RR DLBCL, Including Patients With MYC Alterations
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: CUDC-907-201, NCI-2016-00569, NCT02674750
Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Patients With Lymphoma or Multiple Myeloma
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CUDC-907-101, NCI-2014-00764, NCT01742988
Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CUDC-907-102, NCI-2015-00657, NCT02307240
Start Over